Ginkgo biloba extract EGb761 mitigates ischemic stroke via metabolic pathway modulation
)Abstract
To confirm the therapeutic efficacy of the ginkgo biloba extract EGb761 on ischemic stroke and elucidate its underlying mechanism.
Male Sprague-Dawley rats were divided into three groups: sham, model, and EGb761 (ginkgo biloba extract). Ischemic stroke was then simulated in rats via embolic middle cerebral artery occlusion surgery, with the extract administered half an hour before surgery. Neurological deficit scores, infarct volume, cerebral edema rate, and inflammatory factors served as the primary metrics for drug efficacy. Serum metabolites were analyzed using 1H-nuclear magnetic resonance to elucidate the operative mechanism.
Treatment with the ginkgo biloba extract EGb761 significantly ameliorated the neurological deficit scores (P =.0343), diminished the cerebral infarct volume (P =.0001) and cerebral edema rate (P =.0030), and alleviated neuroinflammation (all P <.05) in middle cerebral artery occlusion rats. In addition, it significantly altered the contents of various metabolites, such as 2-hydroxybutyrate, isoleucine, isopropanol, isobutyric acid, N6-acetyllysine, glutamate, glutamine, methionine, and N,N-dimethylglycine (all P <.05). Enrichment analysis of the differential metabolites indicated that EGb761 may be involved in the regulation of amino acid metabolism, betaine metabolism, glucose-alanine cycle, Warburg effect, and urea cycle.
The ginkgo biloba extract EGb761 demonstrates anti-ischemic stroke effect on ischemic stroke model rats by regulating amino acids and amino acid derivatives, such as isoleucine, N6-acetyllysine, glutamate, methionine, and N,N-dimethylglycine.
References
Béjot Y, Delpont B, Giroud M. Rising stroke incidence in young adults: more epidemiological evidence, more questions to be answered. J Am Heart Assoc. 2016;5(5):e003661.
Liu ZJ, Ran YY, Qie SY, et al. Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway. CNS Neurosci Ther. 2019;25(12):1353-1362.
Yang YB, Li TY, Li ZB, Liu N, Yan YY, Liu B. Role of mitophagy in cardiovascular disease. Aging Dis. 2020;11(2):419-437.
Wu QJ, Tymianski M. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain. 2018;11(1):15.
Sidorov E, Sanghera DK, Vanamala JKP. Biomarker for ischemic stroke using metabolome: a clinician perspective. J Stroke. 2019;21(1):31-41.
Ke CF, Pan CW, Zhang YX, Zhu XH, Zhang YH. Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review. Metabolomics. 2019;15(12):152.
Wang Y, Liu Y, Wu Q, Yao X, Cheng ZQ. Rapid and sensitive determination of major active ingredients and toxic components in GinkgoBiloba leaves extract (EGb 761) by a validated UPLC-MS-MS method. J Chromatogr Sci. 2017;55(4):459-464.
Ahlemeyer B, Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci. 2003;60(9):1779-1792.
Xiao GX, Lyu M, Wang YL, et al. Ginkgo flavonol glycosides or ginkgolides tend to differentially protect myocardial or cerebral ischemia-reperfusion injury via regulation of TWEAK-Fn14 signaling in heart and brain. Front Pharmacol. 2019;10:735.
Yang XH, Zheng TZ, Hong H, et al. Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen-glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model. Front Med. 2018;12(3):307-318.
Erdinyler DS, Karakoy Y, Toplan S, et al. The effect of Ginkgo Biloba glycoside on the blood viscosity and erythrocyte deformability. Clin Hemorheol Microcirc. 1996;16(3):271-276.
Huang SY, Jeng C, Kao SC, Yu JJH, Liu DZ. Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr. 2004;23(4):615-621.
Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? a systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490-502.
Cui M, You TY, Zhao YW, et al. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: results from a pilot randomized trial. Front Pharmacol. 2023;14:1147860.
Chong PZ, Ng HY, Tai JT, Lee SWH. Efficacy and safety of Ginkgo biloba in patients with acute ischemic stroke: a systematic review and meta-analysis. Am J Chin Med. 2020;48(3):513-534.
Zang R, Ling FY, Wu ZY, et al. Ginkgo biloba extract (EGb-761) confers neuroprotection against ischemic stroke by augmenting autophagic/lysosomal signaling pathway. J Neuroimmunol. 2023;382:578101.
Li MZ, Zhang Y, Zou HY, et al. Investigation of Ginkgo biloba extract (EGb 761) promotes neurovascular restoration and axonal remodeling after embolic stroke in rat using magnetic resonance imaging and histopathological analysis. Biomed Pharmacother. 2018;103:989-1001.
Zeng GR, Zhou SD, Shao YJ, et al. Effect of Ginkgo biloba extract-761 on motor functions in permanent middle cerebral artery occlusion rats. Phytomedicine. 2018;48:94-103.
Hui WY, Huang W, Zheng ZG, Li Y, Li P, Yang H. Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF-1α/HK2 pathway. Phytother Res. 2023;37(12):5821-5836.
Yao P, Song FF, Li K, et al. Ginkgo biloba extract prevents ethanol induced dyslipidemia. Am J Chin Med. 2007;35(4):643-652.
Lee MS, Yang DY, Cheng CL, Liang YJ, Yang LL, Cheng FC. Ginkgo biloba extract preserves pyruvate and enhances ascorbate in the cortex of gerbils during focal cerebral ischemia: a microdialysis-liquid chromatography study. J Chromatogr A. 2003;985(1–2):387-394.
Zhang YL, Liu SY, Wan JY, et al. Preparation, characterization and in vivo study of borneol-baicalin-liposomes for treatment of cerebral ischemia-reperfusion injury. Int J Nanomed. 2020;15:5977-5989.
Liu YY, Xue X, Zhang HT, et al. Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia. Autophagy. 2019;15(3):493-509.
Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84-91.
Tchantchou F, Xu YN, Wu YJ, Christen Y, Luo Y. EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease. Faseb J. 2007;21(10):2400-2408.
Tchantchou F, Lacor PN, Cao ZM, et al. Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons. J Alzheimers Dis. 2009;18(4):787-798.
Müller WE, Eckert A, Eckert GP, et al. Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease. World J Biol Psychiatr. 2019;20(3):173-189.
Luo Y, Smith JV, Paramasivam V, et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci USA. 2002;99(19):12197-12202.
Fang WR, Sha L, Kodithuwakku ND, et al. Attenuated blood-brain barrier dysfunction by XQ-1H following ischemic stroke in hyperlipidemic rats. Mol Neurobiol. 2015;52(1):162-175.
Li WJ, Huang RQ, Shetty RA, et al. Transient focal cerebral ischemia induces long-term cognitive function deficit in an experimental ischemic stroke model. Neurobiol Dis. 2013;59:18-25.
Fluri F, Schuhmann MK, Kleinschnitz C. Animal models of ischemic stroke and their application in clinical research. Drug Des Dev Ther. 2015;9:3445-3454.
Pickell Z, Williams AM, Alam HB, Hsu CH. Histone deacetylase inhibitors: a novel strategy for neuroprotection and cardioprotection following ischemia/reperfusion injury. J Am Heart Assoc. 2020;9(11):e016349.
Iadecola C, Gottesman RF. Neurovascular and cognitive dysfunction in hypertension. Circ Res. 2019;124(7):1025-1044.
Herzig V, Cristofori-Armstrong B, Israel MR, Nixon SA, Vetter I, King GF. Animal toxins - nature's evolutionary-refined toolkit for basic research and drug discovery. Biochem Pharmacol. 2020;181:114096.
Zhang JY, Deng ZH, Liao J, et al. Leptin attenuates cerebral ischemia injury through the promotion of energy metabolism via the PI3K/Akt pathway. J Cerebr Blood Flow Metabol. 2013;33(4):567-574.
Sidorov E, Bejar C, Xu C, et al. Potential metabolite biomarkers for acute versus chronic stage of ischemic stroke: a pilot study. J Stroke Cerebrovasc Dis. 2020;29(4):104618.
Liu J, Yuan JL, Zhao JW, Zhang L, Wang Q, Wang G. Serum metabolomic patterns in young patients with ischemic stroke: a case study. Metabolomics. 2021;17(2):24.
Niazi F, Aslam A, Khattak S, Waheed S. Frequency of homocysteinemia in young ischemic stroke patients and its relationship with the early outcome of a stroke. Cureus. 2019;11(9):e5625.
Cui YR, Wu HW, Liu MT, Yang HJ, Qin HJ, Liu X. Effect of Ginkgo biloba leaf extract on cerebral cortex amino acid levels in cerebral ischemia model rats. J Tradit Chin Med. 2018;38(5):676-684.
Vignoli A, Risi E, McCartney A, et al. Precision oncology via NMR-based metabolomics: a review on breast cancer. Int J Mol Sci. 2021;22(9):4687.
Guo ZL, Gu JP, Zhang M, Su F, Su WK, Xie YY. NMR-based metabolomics to analyze the effects of a series of monoamine oxidases-B inhibitors on U251 cells. Biomolecules. 2023;13(4):600.
Yao XJ, Kong XY, Ren JY, et al. Transcranial direct-current stimulation confers neuroprotection by regulating isoleucine-dependent signalling after rat cerebral ischemia-reperfusion injury. Eur J Neurosci. 2023;58(5):3330-3346.
Shen ZH, Xiang M, Chen C, et al. Glutamate excitotoxicity: potential therapeutic target for ischemic stroke. Biomed Pharmacother. 2022;151:113125.
Yang JH, Vitery MDC, Chen JN, Osei-Owusu J, Chu JC, Qiu ZZ. Glutamate-releasing SWELL1 channel in astrocytes modulates synaptic transmission and promotes brain damage in stroke. Neuron. 2019;102(4):813-827.
Mdzinarishvili A, Sumbria R, Lang D, Klein J. Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain. J Pharm Pharmaceut Sci. 2012;15(1):94-102.
Ni YM, Cai LY, Gou XJ, Li WJ, Zhou MM, Huang Y. Therapeutic effect of Sanhua decoction on rats with middle cerebral artery occlusion and the associated changes in gut microbiota and short-chain fatty acids. PLoS One. 2024;19(2):e0298148.
Yin JX, Han PC, Tang ZW, Liu QW, Shi J. Sirtuin 3 mediates neuroprotection of ketones against ischemic stroke. J Cerebr Blood Flow Metabol. 2015;35(11):1783-1789.
Zhong CK, Miao MY, Che BZ, et al. Plasma choline and betaine and risks of cardiovascular events and recurrent stroke after ischemic stroke. Am J Clin Nutr. 2021;114(4):1351-1359.
Li Q, Qu MW, Wang NN, Wang LM, Fan GM, Yang CP. Betaine protects rats against ischemia/reperfusion injury-induced brain damage. J Neurophysiol. 2022;127(2):444-451.
Kopach O, Rusakov DA, Sylantyev S. Multi-target action of β-alanine protects cerebellar tissue from ischemic damage. Cell Death Dis. 2022;13(8):747.
An SJ, Yang YJ, Jeon NM, Hong YP, Kim YI, Kim DY. Significantly reduced alanine aminotransferase level increases all-cause mortality rate in the elderly after ischemic stroke. Int J Environ Res Publ Health. 2021;18(9):4915.
Zhang X, Wu L, Swerdlow RH, Zhao LQ. Opposing effects of ApoE2 and ApoE4 on glycolytic metabolism in neuronal aging supports a Warburg neuroprotective cascade against Alzheimer's disease. Cells. 2023;12(3):410.
Yang SQ, Tang YY, Zeng D, et al. Sodium hydrosulfide reverses β2-microglobulin-induced depressive-like behaviors of male sprague-dawley rats: involving improvement of synaptic plasticity and enhancement of Warburg effect in hippocampus. Behav Brain Res. 2022;417:113562.
Ma Z, Liu D, Zhou M, Gu S, Zuo H. Plasma levels of urea cycle related amino acids in association with risk of ischemic stroke: findings from a nested case-control study. J Stroke Cerebrovasc Dis. 2024;33(2):107531.
Hamaya R, Mora S, Lawler PR, et al. Association of plasma branched-chain amino acid with biomarkers of inflammation and lipid metabolism in women. Circ Genom Precis Med. 2021;14(4):e003330.
Zhenyukh O, González-Amor M, Rodrigues-Diez RR, et al. Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation. J Cell Mol Med. 2018;22(10):4948-4962.
Wang S, Li Q, Zang Y, et al. Apple Polysaccharide inhibits microbial dysbiosis and chronic inflammation and modulates gut permeability in HFD-fed rats. Int J Biol Macromol. 2017;99:282-292.
Alachkar A, Agrawal S, Baboldashtian M, Nuseir K, Salazar J, Agrawal A. L-methionine enhances neuroinflammation and impairs neurogenesis: implication for Alzheimer's disease. J Neuroimmunol. 2022;366:577843.
Wu XJ, Shu QQ, Wang B, Dong L, Hao B. Acetoacetate improves memory in Alzheimer's mice via promoting brain-derived neurotrophic factor and inhibiting inflammation. Am J Alzheimers Dis Other Demen. 2022;37:15333175221124949.
京公网安备11010802044758号